科学图书馆
-
Economic and Quality-of-Life Outcomes of Natriuretic Peptide–Guided Therapy for Heart FailureDB Mark, PA Cowper, KJ Anstrom et al. -
Cardiac and Kidney Benefits of Empagliflozin in Heart Failure Across the Spectrum of Kidney Function: Insights From EMPEROR-ReducedF Zannad, JP Ferreira, SJ Pocock et al.
-
The conductive function of biopolymer corrects myocardial scar conduction blockage and resynchronizes contraction to prevent heart failureS He, J Wu, RK Li et al.
-
Dapagliflozin for treating chronic heart failure with reduced ejection fractionNational Institue for Health and Care Excellence
-
Impact of epicardial adipose tissue on cardiovascular haemodynamics, metabolic profile, and prognosis in heart failureNR Pugliese, F Paneni, M Mazzola et al.
-
Cardiovascular Events Associated With SGLT-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL 2 StudyKosiborod M, Lam CSP, CVD-REAL Investigators and Study Group.
-
Criteria for Iron Deficiency in Patients With Heart FailureG Masini , FJ Graham, P Pellicori et al.
-
Prior Pacemaker Implantation and Clinical Outcomes in Patients With Heart Failure and Preserved Ejection FractionShen L, Jhund PS, McMurray JJV et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
